Skip to main content
Log in

Significance of Angiogenic Factors in Liver Metastatic Tumors Originating from Colorectal Cancers

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We examined the expression of vascularendothelial growth factor (VEGF) and microvessel countsexpressed by CD34 staining in 39 patients with primaryand 44 patients with metastatic liver tumors ofmetastatic colorectal carcinoma, and 29 patients withnonmetastatic colorectal carcinoma as control in orderto determine their value in the evaluation of prognosisand recurrence after hepatectomy. Microvessel counts in primary colorectal carcinomas of themetastatic group were significantly higher than those incontrol (P < 0.05). Neither factor correlated withany clinicopathological feature of primary or metastatic liver carcinomas. Higher microvessel counts inmetastatic liver tumors tended to be associated with ashorter disease-free interval to second recurrence inthe remaining liver (P = 0.069) and were significantly associated with poor prognosis afterhepatectomy (P < 0.05). We conclude that microvesselcount is an important marker of liver metastatasis andprognosis in patients with colorectal carcinoma treated with hepatectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Almersjo O, Bengmark S, Halstrom L: Live r metastasis found by follow-up of patients operated on for colorectal cancer. Cancer 37:1454 -1457, 1976

    Google Scholar 

  2. Blumgart LH, Allison DJ: Resection and embolization in the management of secondary hepatic tumors. World J Surg 6:32- 45, 1982

    Google Scholar 

  3. Orita H, Korenaga D, Maehara Y, Baba H, Sugimachi K: Laminin distribution patterns are closely related to liver me-tastasis in gastric cancer. Cancer 71:1201-1206, 1993

    Google Scholar 

  4. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G: Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 73:575-579, 1994

    Google Scholar 

  5. Nanashima A, Yamaguchi H, Yasutake T, Sawai T, Kusano H, Tagawa Y, Nakagoe T, Ayabe H: Gain of chromosome 20 is a frequent aberration in liver metastasis of colorectal cancers. Dig Dis Sci 42:1388 -1393, 1997

    Google Scholar 

  6. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH: Identi fi cation of angiogenetic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557-562, 1989

    Google Scholar 

  7. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306 -1309, 1989

    Google Scholar 

  8. Plate KH, Breier G, Risau W: Molecular mechanisms of development and tumor angiogenesis. Brain Pathol 4:207-218, 1994

    Google Scholar 

  9. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993

    Google Scholar 

  10. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M: Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72:319 -323, 1995

    Google Scholar 

  11. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, Iki M: Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56:2671-2676, 1996

    Google Scholar 

  12. Saclarides TJ: Angiogenesis in colorectal cancer. Surg Clin North Am 77:253-260, 1997

    Google Scholar 

  13. Miettinen M, Lindenmayer AE, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens: Evaluation of their specifi city and the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82-90, 1994

    Google Scholar 

  14. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K: Microvessel quantifi cation and its possible relation with liver metastasis in colorectal cancer. Cancer 77:1722- 1728, 1996

    Google Scholar 

  15. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T: Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15:826 -832, 1997

    Google Scholar 

  16. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T: Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 39:1073-1080, 1996

    Google Scholar 

  17. Kang SM, Maeda K, Onoda N, Chung YS, Nakata B, Nishiguchi Y, Sowa M: Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74:502-507, 1997

    Google Scholar 

  18. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma, 1st ed. Tokyo, Kane hara & Co., Ltd., 1997

    Google Scholar 

  19. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315-328, 1994

    Google Scholar 

  20. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identifi cation of the KDR tyrosine kinase as a receptor for vascular endothelial ce ll growth factor. Biochem Biophys Res Commun 187:1579 - 1586, 1992

    Google Scholar 

  21. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989 -991, 1992

    Google Scholar 

  22. Tanigawa N, Amaya H, Matsumura M, Lu C, Kitaoka A, Matsuyama K, Muraoka R: Tumor angiogene sis and mode of metastasis in patients with colorectal cancer. Cancer Res 57:1043-1046, 1997

    Google Scholar 

  23. Pritchard AJ, Chatterjee T, Wilkinson M, Powe DG, Gray T, Hewitt RE: Evidence for a weak angiogenic response to human colorectal cancers. Br J Cancer 71:1081-1086, 1995

    Google Scholar 

  24. Muramatsu Y, Takayasu K, Moriyama N, Shima Y, Goto H, Ushio K, Yamada T, Hasegawa H, Koyama Y, Hirohashi S: Peripheral loe-density area of hepatic tumors: CT-pathologic correlation. Radiology 160:49 -52, 1986

    Google Scholar 

  25. Machover D: A comprehensive review of 5-fl uorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 80:1179 -1187, 1997

    Google Scholar 

  26. Tanaka T, Konno H, Matsuda I, Nakamura S, Baba S: Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Res 55:836 -839, 1995

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nanashima, A., Ito, M., Sekine, I. et al. Significance of Angiogenic Factors in Liver Metastatic Tumors Originating from Colorectal Cancers. Dig Dis Sci 43, 2634–2640 (1998). https://doi.org/10.1023/A:1026643009152

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026643009152

Navigation